Stockscreener 앱 받기
11.89
0.25%
-0.03
시간 외 거래:
12.14
0.25
+2.10%
전일 마감가:
$11.92
열려 있는:
$12.25
하루 거래량:
40,781
Relative Volume:
0.98
시가총액:
$22.35M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.94%
1개월 성능:
+56.65%
6개월 성능:
+129.09%
1년 성능:
+0.00%
1일 변동 폭
$11.35
$12.62
1주일 범위
$11.00
$13.25
52주 변동 폭
$2.90
$13.34
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
11.89 | 22.41M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
How to build a dashboard for Neuphoria Therapeutics Inc. stockTrade Risk Summary & Fast Exit and Entry Strategy Plans - Newser
What data driven models say about Neuphoria Therapeutics Inc.’s futureWeekly Market Summary & Safe Entry Zone Identification - Newser
Why is Neuphoria Therapeutics Inc. stock going upPortfolio Update Summary & Expert Approved Trade Ideas - خودرو بانک
Is Neuphoria Therapeutics Inc. being accumulated by smart moneyQuarterly Profit Report & Accurate Intraday Trading Signals - خودرو بانک
Can Neuphoria Therapeutics Inc. recover in the next quarterQuarterly Profit Report & Weekly Market Pulse Updates - Newser
Is Neuphoria Therapeutics Inc. affected by consumer sentimentJuly 2025 PreEarnings & AI Forecast Swing Trade Picks - خودرو بانک
Neuphoria completes enrollment for phase 3 anxiety drug trial By Investing.com - Investing.com Nigeria
Will Neuphoria Therapeutics Inc. outperform the marketWeekly Gains Summary & Breakout Confirmation Trade Signals - Newser
Statistical indicators supporting Neuphoria Therapeutics Inc.’s strengthPortfolio Growth Summary & Community Verified Trade Alerts - Newser
Can momentum traders help lift Neuphoria Therapeutics Inc.IPO Watch & Safe Capital Preservation Plans - Newser
Analyzing recovery setups for Neuphoria Therapeutics Inc. investorsWeekly Profit Recap & Verified Momentum Watchlists - Newser
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder - MarketScreener
Is Neuphoria Therapeutics Inc. a stock for growth or value investors2025 Investor Takeaways & Capital Protection Trading Alerts - خودرو بانک
Neuphoria completes enrollment for phase 3 anxiety drug trial - Investing.com
Neuphoria Therapeutics achieves target enrollment in AFFIRM-1 Phase 3 trial for BNC-210. - AInvest
Neuphoria Therapeutics Completes Target Enrollment in Phase - GlobeNewswire
Neuphoria Therapeutics Achieves Target Enrollment in Phase 3 AFFIRM-1 Trial for BNC-210 in Social Anxiety Disorder. - AInvest
Neuphoria Therapeutics Completes Target Enrollment in Phase 3 AFFIRM-1 Trial of BNC-210 in Social Anxiety Disorder (SAD) - GlobeNewswire Inc.
Will Neuphoria Therapeutics Inc. benefit from macro trendsGold Moves & Safe Entry Zone Tips - Newser
Using flow based indicators on Neuphoria Therapeutics Inc.Rate Cut & AI Optimized Trading Strategy Guides - Newser
Chart based exit strategy for Neuphoria Therapeutics Inc.July 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - Newser
Will Neuphoria Therapeutics Inc. continue its uptrend2025 Performance Recap & Verified Trade Idea Suggestions - Newser
Is Neuphoria Therapeutics Inc. attractive for institutional investorsJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - خودرو بانک
Technical analysis overview for Neuphoria Therapeutics Inc. stock2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
Is it too late to sell Neuphoria Therapeutics Inc.July 2025 Patterns & Daily Technical Stock Forecast Reports - Newser
Can you recover from losses in Neuphoria Therapeutics Inc.Forecast Cut & Real-Time Volume Spike Alerts - Newser
What is the long term forecast for Neuphoria Therapeutics Inc. stockJuly 2025 Final Week & High Conviction Investment Ideas - خودرو بانک
Has Neuphoria Therapeutics Inc. formed a bullish divergenceEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
How to forecast Neuphoria Therapeutics Inc. trends using time seriesEarnings Trend Report & Stepwise Trade Execution Plans - Newser
What to do if you’re stuck in Neuphoria Therapeutics Inc.2025 AllTime Highs & Intraday High Probability Alerts - Newser
Sentiment analysis tools applied to Neuphoria Therapeutics Inc.July 2025 Retail & Safe Capital Investment Plans - Newser
Using portfolio simulators with Neuphoria Therapeutics Inc. included2025 Market Trends & Technical Confirmation Trade Alerts - Newser
Is Neuphoria Therapeutics Inc.’s ROIC above industry average2025 Historical Comparison & Technical Entry and Exit Alerts - خودرو بانک
Exit strategy if you’re trapped in Neuphoria Therapeutics Inc.Weekly Volume Report & Fast Entry and Exit Trade Plans - Newser
Will Neuphoria Therapeutics Inc. benefit from AI trendsPortfolio Return Report & Real-Time Buy Signal Notifications - خودرو بانک
Is Neuphoria Therapeutics Inc. stock ready for a breakoutJuly 2025 Trade Ideas & Free Risk Controlled Daily Trade Plans - Newser
Published on: 2025-09-02 13:20:15 - خودرو بانک
Why Neuphoria Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Update & Safe Investment Capital Preservation Plans - 한국정경신문
Published on: 2025-09-01 23:03:57 - Newser
Developing predictive dashboards with Neuphoria Therapeutics Inc. dataJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
What momentum shifts mean for Neuphoria Therapeutics Inc.2025 Price Momentum & Smart Investment Allocation Tips - Newser
What are the future prospects of Neuphoria Therapeutics Inc.July 2025 News Drivers & Free Growth Oriented Trading Recommendations - خودرو بانک
Neuphoria Therapeutics Inc (NEUP) 재무 분석
Neuphoria Therapeutics Inc (NEUP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):